The growth factor receptors including ERBB2, ERBB3 and EGFR have been found to be altered or amplified in bladder cancer and have the potential to activate PI3K/AKT signaling pathway [49]. The gene discussed is ERBB3; the disease is urinary bladder carcinoma.